Skip to main content
. 2017 Aug;9(8):2560–2571. doi: 10.21037/jtd.2017.07.117

Table 1. Demographic baseline and PD-L1 expression assessment of the studies.

First author and year of publication Classification of lung cancer Ethnicity Assessment of IHC staining Cut off for PD-L1 positive Reference
Kim 2015 SQCC Asia Percentage 10% (15)
D’Incecco 2015 NSCLC Non-Asia H-score 10 (14)
Cooper 2015 NSCLC Non-Asia Percentage 50% (16)
Chang 2015 LLC Asia Percentage 5% (17)
Yang 2014 AD Asia Percentage 5% (18)
Yang 2016 SQCC Asia Percentage 5% (19)
Zhang 2014 AD Asia Quickscore 8 (20)
Tang 2015 NSCLC Asia H-score 5 (13)
Rizvi 2015 NSCLC Non-Asia Percentage 1% (10)
Ji 2016 AD Asia H-score 10 (21)
Scheel 2016 NSCLC Asia Percentage 1% (22)
Chang 2016 pleomorphic carcinoma Asia Percentage 5% (23)
Fang 2015 LLC Asia Percentage 5% (24)
Inoue 2016 NSCLC Asia H-score 5 (25)
Koh 2015 AD Asia Percentage 5% (26)
Tao 2016 SCLC Asia Percentage 5% (27)
Ameratunga 2016 NSCLC Non-Asia H-score 100 (28)
Velcheti 2014 NSCLC Non-Asia NA NA (29)
Mu 2011 NSCLC Asia H-score Median value (30)
Chen 2013 NSCLC Asia H-score 9 (31)
Chen 2012 NSCLC Asia H-score 3 (32)
Takada 2016 AD Asia Percentage 1% (33)
Song 2016 AD Asia Percentage 5% (34)
Song 2016 SQCC Asia H-score 5 (35)
Calles 2015 NSCLC Non-Asia Percentage 5% (36)
Shimoji 2016 NSCLC Asia NA NA (37)
Schmidt 2015 NSCLC Non-Asia Percentage 5% (38)
Sorensen 2016 NSCLC Non-Asia Percentage 1% (39)
Chen 2016 NSCLC Asia Allred score 1 (40)
Jiang 2015 LLC Asia Percentage 5% (41)
Sun 2016 NSCLC Asia Percentage 1% (42)
Lin 2015 AD Asia H score Mean H-score (43)
Jia 2016 NSCLC Asia Percentage 10% (44)
Huynh 2016 AD Non-Asia Percentage 5% (45)

Quickscore = SI (staining intensity) × PPC (percentage of positive cells score). SI was determined as: 0, negative; 1, weak; 2, moderate; and 3, strong. PPC was defined as: 1, 0–4%; 2, 5–19%; 3, 20–39%; 4, 40–59%; 5, 60–79%; 6, 80–100%. H-score = summation (1+i)pi. PD-L1, programmed death-ligand 1; AD, adenocarcinoma; LLC, lymphoepithelioma-like carcinoma; NSCLC, non-small cell lung cancer; SQCC, squamous cell lung carcinoma.